Vancouver, B.C., June 17, 2021 – Further to its press release date May 17, 2021, Awakn Life Sciences Corp. (formerly 1169082 B.C. Ltd.) (the " Company ") is pleased to announce that it has completed its reverse takeover transaction (the " Transaction ") of Awakn Life Sciences Inc. (" Awakn "), and that the net proceeds from its previously announced brokered private placement of 3,320,220 subscription receipts for aggregate gross proceeds of $8,300,550 (the " Offering ")have been released from escrow to Awakn. The Company has also received final approval to list its common shares on the Neo Exchange Inc. (" NEO "), and trading is expected to commence on June 23, 2021 under the stock symbol "AWKN" (CUSIP: 05455W108).